ARTICLE | Company News
Life Science Pharmaceuticals, Ludwig Institute for Cancer Research deal
June 5, 2006 7:00 AM UTC
The institute granted Life Science exclusive worldwide rights to develop and commercialize three MAbs for cancer and autoimmune diseases. The antibodies target epidermal growth factor receptor (EGFR)...